Platelet Changes in Type 2 Diabetes
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age30-70
SponsorAssiut University
About this trial
This study examines changes in platelet indices in people with type 2 diabetes compared to healthy people. It checks if these changes relate to inflammation markers (like hs-CRP) and blood sugar control. Participants get routine blood tests during one clinic visit at Assiut University Hospitals. No treatments or extra procedures are involved.
Eligibility criteria
Qualifiers
Adults aged 30-70 years.
Diagnosed T2DM for at least 1 year.
Fasting blood glucose ≥126 mg/dL and/or HbA1c ≥ 6.5%
Disqualifiers
Type 1 Diabetes Mellitus
Acute infection, chronic inflammatory disease
Malignancy.
Current use of anti-platelet or anti-inflammatory medications
Trial design
Treatments tested in this trial
- Not listed
Trial groups
200 Participants
are grouped into 2 trial groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov